End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
86,100 KRW | -2.49% | -1.60% | -14.24% |
May. 10 | SK Biopharmaceuticals Turns to Profit in Q1 as Sales Jump 88% | MT |
Jan. 30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
ETFs positioned on SK Biopharmaceuticals Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.83% | 2 M€ | -14.14% | ||
0.08% | 15 M€ | +21.38% | ||
0.03% | 2,867 M€ | +10.49% | - | |
0.03% | 454 M€ | +8.42% | - | |
0.03% | 153 M€ | +7.93% | - | |
0.03% | 4 M€ | -4.41% | - | |
0.01% | 7 M€ | +5.57% | - | |
0.01% | 112 M€ | +4.91% | - | |
0.00% | 45 M€ | 0.00% | - | |
0.00% | 34 M€ | +9.41% | - | |
0.00% | 34 M€ | +4.00% | - | |
0.00% | 306 M€ | +6.68% | - | |
0.00% | 39 M€ | +6.13% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.24% | 4.94B | |
+17.38% | 79.38B | |
+9.28% | 8.74B | |
+49.95% | 4.7B | |
+5.96% | 3.98B | |
+12.83% | 2.28B | |
-23.57% | 2.28B | |
+17.77% | 2.14B | |
-32.28% | 2.12B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- A326030 Stock
- Funds and ETFs SK Biopharmaceuticals Co., Ltd.